Menu Icon Created with Sketch Beta.

Unlocking Protein Degradation

Plexium

Previous Post Left arrow Next Post Right Arrow

Plexium focuses on targeted protein degraders to reinvent the way medicines are discovered.

The company's DELPhe platform, named for DNA-Encoded Library (DEL) phenotypic (Phe) screening, is a unique drug discovery engine designed to identify novel small molecules for multiple indications, including cancer and inflammatory disease indications.

View All Companies